Basit öğe kaydını göster

dc.contributor.authorGüzel, Ahmet
dc.contributor.authorKanter, Mehmet
dc.contributor.authorGüzel, Aygül
dc.contributor.authorPergel, Ahmet
dc.contributor.authorErboğa, Mustafa
dc.date.accessioned2020-12-19T20:16:40Z
dc.date.available2020-12-19T20:16:40Z
dc.date.issued2012
dc.identifier.citationGuzel, A., Kanter, M., Guzel, A., Pergel, A., & Erboga, M. (2012). Anti-inflammatory and antioxidant effects of infliximab on acute lung injury in a rat model of intestinal ischemia/reperfusion. Journal of molecular histology, 43(3), 361–369. https://doi.org/10.1007/s10735-012-9396-0en_US
dc.identifier.issn1567-2379
dc.identifier.urihttps://doi.org/10.1007/s10735-012-9396-0
dc.identifier.urihttps://hdl.handle.net/11436/4237
dc.descriptionPubMed: 22389028en_US
dc.description.abstractThe purpose of this study was to investigate the role of infliximab on acute lung injury induced by intestinal ischemia/reperfusion (I/R). A total of 30 male Wistar albino rats were divided into three groups: Sham, I/R and I/R? infliximab; each group contain 10 animals. Sham group animals underwent laparotomy without I/R injury. After I/R groups animals underwent laparotomy, 1 h of superior mesenteric artery ligation were followed by 1 h of reperfusion. In the infliximab group, 3 days before I/R, infliximab (3 mg/kg) was administered by intravenously. All animals were sacrificed at the end of reperfusion and lung tissues samples were obtained for biochemical and histopathological investigation in all groups. To date, no more biochemical and histopathological changes on intestinal I/R injury in rats by infliximab treatment have been reported. Infliximab treatment significantly decreased the elevated tissue malondialdehyde levels and increased of reduced superoxide dismutase, and glutathione peroxidase enzyme activities in lung tissues samples. Intestinal I/R caused severe histopathological injury including edema, hemorrhage, increased thickness of the alveolar wall and a great number of inflammatory cells that infiltrated the interstitium and alveoli. Infliximab treatment significantly attenuated the severity of intestinal I/R injury. Furthermore, there is a significant reduction in the activity of inducible nitric oxide synthase and arise in the expression of surfactant protein D in lung tissue of acute lung injury induced by intestinal I/R with infliximab therapy. It was concluded that infliximab treatment might be beneficial in acute lung injury, therefore, shows potential for clinical use. Because of its anti-inflammatory and antioxidant effects, infliximab pretreatment may have protective effects in acute lung injury induced by intestinal I/R. © Springer Science+Business Media B.V. 2012.en_US
dc.language.isoengen_US
dc.publisherSpringer Linken_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAcute lung injuryen_US
dc.subjectInfliximaben_US
dc.subjectINOS and surfactant protein Den_US
dc.subjectIntestinal ischemiaen_US
dc.subjectOxidative stressen_US
dc.subjectRaten_US
dc.subjectReperfusionen_US
dc.titleAnti-inflammatory and antioxidant effects of infliximab on acute lung injury in a rat model of intestinal ischemia/reperfusionen_US
dc.typearticleen_US
dc.contributor.departmentRTEÜ, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümüen_US
dc.contributor.institutionauthorPergel, Ahmet
dc.identifier.doi10.1007/s10735-012-9396-0
dc.identifier.volume43en_US
dc.identifier.issue3en_US
dc.identifier.startpage361en_US
dc.identifier.endpage369en_US
dc.relation.journalJournal of Molecular Histologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster